Success rates for in vitro fertilization are higher at clinics that voluntarily share more information than required by government regulators, according to new research by faculty at the University of Colorado School of Medicine.
In a review of data reported between 2014 and 2017, CU researchers found that clinics that reported more data than required by the Centers for Disease Control and Prevention (CDC) had higher rates of success in achieving pregnancy and birth.
“It was stunning to see the difference,” said Alex J. Polotsky, MD, professor of obstetrics and gynecology in the Division of Advance Reproductive Medicine at CU. “The data showed that clinics with high transparency had greater success. When you go to a clinic with high transparency, it means you are much more likely to have healthy baby.”
In a review presented Sunday, October 18, at the American Society for Reproductive Medicine’s annual meeting, Polotsky and his colleagues compared the outcomes at clinics that report the minimum data required by the CDC and those clinics that share more information through a professional organization, the Society for Assisted Reproductive Technology (SART).
The review compared rates of pregnancy, live birth, good birth outcome, and cases when the IVF cycle is cancelled. The cancellation rates were higher at the clinics meeting the higher transparency standards required by SART, indicating that the procedure moves forward when the likelihood for success is higher. SART posts national data and reports from member clinics on its website.
“Nobody had compared clinics that adhered to higher standards of transparency,” said Polotsky, who is the medical director for CU Advanced Reproductive Medicine. “This shows that it is better for patients when clinics share more information that is easier to understand.”
National study identifies best method for achieving a healthy IVF birth
IVF success rates higher at clinics that provide more outcomes data (2020, October 18)
retrieved 18 October 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- Americans Are Cutting Back on Sugary Drinks - October 19, 2020
- ‘Multi-omics’ adds new cell to immune family tree - October 19, 2020
- Hospitalised COVID-19 patients first in UK to receive antibody treatment in RECOVERY trial - October 19, 2020
- Reopened Schools in New York City Not Seeing COVID Case Spikes - October 19, 2020
- 9 Things You Need to Know About Life Insurance - October 19, 2020
- Exercise Ups Life Span for Type 2 Diabetics - October 19, 2020
- How melanoma deceives the immune system, increasing resistance to immunotherapy - October 19, 2020
- Antivirals have little effect on mortality in patients hospitalised with COVID-19, suggest WHO trial interim results - October 19, 2020
- Newer Rheumatoid Arthritis Drug May Help Ease Tough-to-Treat Cases - October 19, 2020
- Garmin® introduces the Venu GPS smartwatch with stunning AMOLED display - October 19, 2020